RIMADYL PALATABLE TABLETS 50 MG

Valsts: Īrija

Valoda: angļu

Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)

Aktīvā sastāvdaļa:

CARPROFEN

Pieejams no:

Zoetis Ireland Limited

ATĶ kods:

QM01AE91

SNN (starptautisko nepatentēto nosaukumu):

CARPROFEN

Deva:

50 mg/tablet

Zāļu forma:

Tablets

Receptes veids:

POM: Prescription Only Medicine as defined in relevant national legislation

Ārstniecības grupa:

Canine

Ārstniecības joma:

carprofen

Ārstēšanas norādes:

N.S.A.I.D

Autorizācija statuss:

Authorised

Autorizācija datums:

2015-03-06

Produkta apraksts

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Rimadyl Palatable Tablets 50 mg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 50 mg Carprofen.
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Chewable tablets.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For analgesia and reduction of chronic inflammation, for example in
degenerative joint disease, in the dog.
Rimadyl Palatable Tablets can also be used in the management of
post-operative pain.
4.3 CONTRAINDICATIONS
Do not exceed the stated dose.
The elimination time of NSAIDs, including carprofen, in the cat is
longer than in the dog and the therapeutic index is
narrower.
In the absence of specific data the use of Rimadyl Palatable Tablets
in the cat is contra-indicated.
Do not use in dogs suffering from cardiac, hepatic or renal disease,
where there is a possibility of gastro-intestinal
ulceration or bleeding, or where there is evidence of blood dyscrasia
or hypersensitivity to the product.
Do not administer other NSAIDs concurrently or within 24 hours of each
other.
Some NSAIDs may be highly bound
to plasma proteins and compete with other highly bound drugs, which
can lead to toxic effects.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_3_
_1_
_/_
_0_
_3_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_2_
_4_
_1_
_5_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_